News & Events

In this large collaborative study with partners from DKFZ, Bayer and others, OmicScouts proteomic technologies helped to identify the target and mechanism of NCT02, a compound that...
Proteins are the most important biochemical function carriers. Their totality is called the proteome. Since the proteome of a cell or an organism is strongly influenced by external...
Nov. 1, 2020
To strengthen our multidisciplinary team, we are looking for Research Associate Biochemistry and Mass Spectrometry (MS)-based Proteomics Computational Biologist or Bioinformati...
Together with our partners at the TUM Chair of Proteomics and Bioanalytics and the TUM Institute of Virology, we received grant funding of the Bayrische Forschungsstiftung for a pr...
Together with the Medical University of Vienna, TAmiRNA GmbH, and other partners, OmicScouts published a study on the combined used of proteomics and miRNomics as screening tools f...
Nov. 11 - Nov. 13, 2019
OmicScouts will attend the premier partnering conference BIO-Europe. Take the opportunity and meet us in Hamburg between 11th and 13th November 2019. Meet our experts to discuss yo...
We are expanding our technology portfolio: We now support our drug discovery clients working in the field of event-driven pharmacology with our TurnoverScout™ technology. As more ...
Juni 17 - Juni 20, 2019
Join us at the the World Pharma Week in Boston. We will speak in the Chemical Biology and Target Validation track on June 18, 2019 about using proteomics and chemical proteomics to...
We congratulate our co-founders and scientific advisors Bernhard Kuster and Mathias Wilhelm and their colleagues and collaborators at SAP, JPT Peptide Technologies and Thermo Fishe...
Mai 13 - Mai 14, 2019
Join us at the the Neuro4D conference in Mainz, Germany. Our CEO, Hannes Hahne, will present work we have done together with our partner, Rodin Therapeutics, on complex-selective H...
März 24 - März 28, 2019
We will be present at the the Proteomic Forum 2019 in Potsdam, the Annual meeting of the German Society for Proteome Research. If you would like to get in touch, feel free to drop ...
März 18, 2019
Dear colleagues, We hope that you and your loved ones stay safe and healthy during these uncertain, challenging times. As COVID-19 continues to spread around the globe, and impact...
Numerous colleagues will be present at the EMBL conference "Proteomics in Cell Biology and Disease Mechanisms" 2019 in Heidelberg, Germany. If you would like to get in touch, feel ...
Our CEO, Hannes Hahne, will give a talk on "Proteomics for Target and Pathway Deconvolution" at the ELRIG Forum in Darmstadt, Germany. Feel free to drop us an e-mail (info(at)omics...
Together with the TU Munich, the Science for Life Laboratory at the KTH Royal Institute of Technology in Stockholm and at the Uppsala University, we generated a quantitative proteo...
Kinase inhibitors are an important class of drugs that block protein kinases involved in diseases such as cancer and inflammatory disorders. A large effort led by the academic lab ...
We congratulate our co-founder Mathias Wilhelm for being awarded the 2017 Promotion Price of the German proteomics society (DGPF) for an outstanding dissertation on ProteomicsDB ("...
Together with our partners at Xellutec, GenXPro and the Universities of Heidelberg and Tübingen, and the Technical University of Munich, we published a comprehensive molecular port...
Join us at the the 4th annual Chemical Biology in Drug Discovery conference in Boston. Our CEO will talk about mass Spectrometry-based proteomics in preclinical drug discovery. Fin...
We will be present at the the Proteomic Forum 2017 in Potsdam, the Annual meeting of the German Society for Proteome Research. Find out more about the conference and the programme ...